- call +1-201-465-4211
- email sales@mrinsights.biz
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
Scope of the Report:
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
The worldwide market for Pneumococcal Vaccine is expected to grow at a CAGR of roughly 1.0% over the next five years, will reach 7580 million US$ in 2024, from 7140 million US$ in 2019, according to a new study.
This report focuses on the Pneumococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PPSV 23
PCV 7/13
PCV 10
Market Segment by Applications, can be divided into
Child
Adult
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine in 2017 and 2018.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pneumococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 PPSV 23
1.2.2 PCV 7/13
1.2.3 PCV 10
1.3 Market Analysis by Applications
1.3.1 Child
1.3.2 Adult
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Pneumococcal Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Pneumococcal Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 MSD
2.3.1 Business Overview
2.3.2 Pneumococcal Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofipasteur
2.4.1 Business Overview
2.4.2 Pneumococcal Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CDIBP
2.5.1 Business Overview
2.5.2 Pneumococcal Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pneumococcal Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pneumococcal Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pneumococcal Vaccine Market Analysis by Regions
4.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumococcal Vaccine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Regions (2014-2019)
4.2 North America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.3 Europe Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.5 South America Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5 North America Pneumococcal Vaccine by Country
5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
5.2 United States Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5.3 Canada Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
5.4 Mexico Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6 Europe Pneumococcal Vaccine by Country
6.1 Europe Pneumococcal Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
6.2 Germany Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.3 UK Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.4 France Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.5 Russia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
6.6 Italy Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pneumococcal Vaccine by Country
7.1 Asia-Pacific Pneumococcal Vaccine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
7.2 China Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.3 Japan Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.4 Korea Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.5 India Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8 South America Pneumococcal Vaccine by Country
8.1 South America Pneumococcal Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
8.1.2 South America Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8.3 Argentina Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
8.4 Colombia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pneumococcal Vaccine by Countries
9.1 Middle East and Africa Pneumococcal Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pneumococcal Vaccine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pneumococcal Vaccine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.3 Turkey Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.4 Egypt Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.5 Nigeria Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
9.6 South Africa Pneumococcal Vaccine Sales and Growth Rate (2014-2019)
10 Global Pneumococcal Vaccine Market Segment by Type
10.1 Global Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pneumococcal Vaccine Sales and Market Share by Type (2014-2019)
10.1.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2014-2019)
10.2 PPSV 23 Sales Growth and Price
10.2.1 Global PPSV 23 Sales Growth (2014-2019)
10.2.2 Global PPSV 23 Price (2014-2019)
10.3 PCV 7/13 Sales Growth and Price
10.3.1 Global PCV 7/13 Sales Growth (2014-2019)
10.3.2 Global PCV 7/13 Price (2014-2019)
10.4 PCV 10 Sales Growth and Price
10.4.1 Global PCV 10 Sales Growth (2014-2019)
10.4.2 Global PCV 10 Price (2014-2019)
11 Global Pneumococcal Vaccine Market Segment by Application
11.1 Global Pneumococcal Vaccine Sales Market Share by Application (2014-2019)
11.2 Child Sales Growth (2014-2019)
11.3 Adult Sales Growth (2014-2019)
12 Pneumococcal Vaccine Market Forecast (2019-2024)
12.1 Global Pneumococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
12.2 Pneumococcal Vaccine Market Forecast by Regions (2019-2024)
12.2.1 North America Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.2 Europe Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.4 South America Pneumococcal Vaccine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pneumococcal Vaccine Market Forecast (2019-2024)
12.3 Pneumococcal Vaccine Market Forecast by Type (2019-2024)
12.3.1 Global Pneumococcal Vaccine Sales Forecast by Type (2019-2024)
12.3.2 Global Pneumococcal Vaccine Market Share Forecast by Type (2019-2024)
12.4 Pneumococcal Vaccine Market Forecast by Application (2019-2024)
12.4.1 Global Pneumococcal Vaccine Sales Forecast by Application (2019-2024)
12.4.2 Global Pneumococcal Vaccine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pneumococcal Vaccine Picture
Table Product Specifications of Pneumococcal Vaccine
Figure Global Sales Market Share of Pneumococcal Vaccine by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
